HMGA2 is down-regulated by microRNA let-7 and associated with epithelial-mesenchymal transition in oesophageal squamous cell carcinomas of Kazakhs

Histopathology

Volumn 65, Issue 3, 2014, Pages 408-417

  Liu, Qing ^a   Liu, Tao ^a   Zheng, Shutao ^a   Gao, Xiangpeng ^a   Lu, Mang ^a   Sheyhidin, Ilyar ^a   Lu, Xiaomei ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

High mobility group A2 protein; Kazakh; Let 7; Oesophageal squamous cell carcinoma; Snail

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN; MICRORNA; MICRORNA LET 7; UNCLASSIFIED DRUG; MIRNLET7 MICRORNA, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ARTICLE; CANCER PATIENT; CELL CULTURE; CELL PROLIFERATION; CHINA; DOWN REGULATION; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ETHNIC GROUP; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KAZAKH (PEOPLE); MALE; PRIORITY JOURNAL; RNA EXTRACTION; SQUAMOUS EPITHELIUM; WILD TYPE; ESOPHAGUS TUMOR; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

GASTROPODA;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CHINA; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; ESOPHAGEAL NEOPLASMS; ETHNIC GROUPS; FEMALE; HMGA2 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICRORNAS; MIDDLE AGED; TRANSCRIPTION FACTORS;

EID: 84921934369     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12401     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM et al. Global cancer statistics. CA Cancer J. Clin. 2011; 61; 69-90.
2. Rohatgi PR, Swisher SG, Correa AM et al. Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy. Cancer 2006; 106; 552-558.
3. Gholipour C, Shalchi RA, Abbasi M. A histopathological study of esophageal cancer on the western side of the Caspian littoral from 1994 to 2003. Dis. Esophagus 2008; 21; 322-327.
4. Tran GD, Sun XD, Abnet CC et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int. J. Cancer 2005; 113; 456-463.
5. Zheng ST, Vuitton L, Sheyhidin I et al. Northwestern China: a place to learn more on oesophageal cancer. Part one: behaviour and environmental risk factors. Eur. J. Gastroenterol. Hepatol. 2010; 22; 917-925.
6. Enzinger PC, Mayer RJ. Esophageal cancer. N. Engl. J. Med. 2003; 349; 2241-2252
7. Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J. Clin. 2005; 55; 74-108.
8. Di Leva G, Croce CM. miRNA profiling of cancer. Curr. Opin. Genet. Dev. 2013; 23; 3-11.
9. Lieberman J. Micromanaging cancer. N. Engl. J. Med. 2009; 361; 1500-1501.
10. Liang YJ, Wang QY, Zhou CX et al. MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis 2013; 34; 713-722.
11. Yokobori T, Suzuki S, Tanaka N et al. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1. Cancer Sci. 2013; 104; 48-54.
12. Bao L, Yan Y, Xu C et al. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways. Cancer Lett. 2013; 337; 226-236.
13. Reinhart BJ, Slack FJ, Basson M et al. The 21 nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000; 403; 901-906.
14. Pan L, Gong Z, Zhong Z et al. Lin-28 reactivation is required for let-7 repression and proliferation in human small cell lung cancer cells. Mol. Cell. Biochem. 2011; 355; 257-263.
15. King CE, Wang L, Winograd R et al. LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms. Oncogene 2011; 30; 4185-4193.
16. Tu HF, Lin SC, Chang KW. MicroRNA aberrances in head and neck cancer: pathogenetic and clinical significance. Curr. Opin. Otolaryngol. Head Neck Surg. 2013; 21; 104-111.
17. Ali S, Almhanna K, Chen W et al. Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer. Am. J. Transl. Res. 2010; 3; 28-47.
18. Chang CJ, Hsu CC, Chang CH et al. Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer. Oncol. Rep. 2011; 26; 1003-1010.
19. Guo L, Chen C, Shi M et al. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition. Oncogene 2013; 32; 5272-5282.
20. Cleynen I, Van de Ven WJ. The HMGA proteins: a myriad of functions (Review). Int. J. Oncol. 2008; 32; 289-305.
21. Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between Let-7 and HMGA2 enhances oncogenic transformation. Science 2007; 315; 1576-1579.
22. Tan EJ, Thuault S, Caja L et al. Regulation of transcription factor Twist expression by the DNA architectural protein high mobility group A2 during epithelial-to-mesenchymal transition. J. Biol. Chem. 2012; 287; 7134-7145.
23. Liu Q, Lv GD, Qin X et al. Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. Mol. Biol. Rep. 2012; 39; 1239-1246.
24. Mathé EA, Nguyen GH, Bowman ED et al. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin. Cancer Res. 2009; 15; 6192-6200.
25. Guo Y, Chen Z, Zhang L et al. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res. 2008; 68; 26-33.
26. Takamizawa J, Konishi H, Takahashi T et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004; 64; 3753-3756.
27. Liang S, He L, Zhao X et al. MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLoS One 2011; 6; e18409.
28. Liu P, Qi M, Ma C et al. Let7a inhibits the growth of endometrial carcinoma cells by targeting Aurora-B. FEBS Lett. 2013; 587; 2523-2529.
29. Haselmann V, Kurz A, Bertsch U et al. Nuclear death receptor TRAIL-R2 inhibits maturation of Let-7 and promotes proliferation of pancreatic and other tumor cells. Gastroenterology 2014; 146; 278-290.
30. Boyerinas B, Park SM, Shomron N et al. Identification of let-7-regulated onco fetal genes. Cancer Res. 2008; 68; 2587-2591.
31. Di Cello F, Hillion J, Hristov A et al. HMGA2 participates in transformation in human lung cancer. Mol. Cancer Res. 2008; 6; 743-750.
32. Meyer B, Loeschke S, Schultze A et al. HMGA2 overexpression in non-small cell lung cancer. Mol. Carcinogen. 2007; 46; 503-511.
33. Motoyama K, Inoue H, Nakamura Y et al. Clinical significance of high mobility groupA2 in human gastric cancer and its relationship to let-7 microRNA family. Clin. Cancer Res. 2008; 14; 2334-2340.
34. Miyazawa J, Mitoro A, Kawashiri S et al. Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity. Cancer Res. 2004; 64; 2024-2029.
35. Usami Y, Satake S, Nakayama F et al. Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression. J. Pathol. 2008; 215; 330-339.
36. Franz M, Spiegel K, Umbreit C et al. Expression of Snail is associated with myofibroblast phenotype development in oral squamous cell carcinoma. Histochem. Cell Biol. 2009; 131; 651-660.
37. Natsugoe S, Uchikado Y, Okumura H et al. Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma. Oncol. Rep. 2007; 17; 517-523.